Pharmacology News and Research

Latest Pharmacology News and Research

Ensuring heart safety of non-heart drugs

Current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of drugs developed primarily for non-cardiovascular medical problems, according to a recent presentation made by Dr. Jeffrey Borer, an authority in cardiovascular medicine and surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

2 Jan 2008

Cell-death receptor links cancer susceptibility and inflammation

For over 10 years, Wafik S. El-Deiry, MD, PhD, Professor of Medicine, Genetics, and Pharmacology at the University of Pennsylvania School of Medicine, has been pursuing a cancer-targeting molecule called TRAIL and its molecular partners.

28 Dec 2007

Hardening of the arteries - mutant gene identified as culprit

A genetic mutation expands lesions in the aorta and promotes coronary atherosclerosis, more commonly known as hardening of the arteries, according to a study by Yale School of Medicine in Cell Metabolism.

20 Dec 2007

Discovery of new ALS gene

The ALS research team at Umea University in Sweden, working with Dutch and Belgian colleagues, has found new connections between mutations in gene DPP6 and contracting the non-hereditary form of ALS. The findings are being published december 16 in Nature Genetics on the Web.

18 Dec 2007

Researchers spearhead key genome initiative

The complete collection of genes - the genome - of a moss has been sequenced, providing scientists an important evolutionary link between single-celled algae and flowering plants.

17 Dec 2007

Researchers find genetic switch for internal body clock

University of California, Irvine researchers have identified the chemical switch that triggers the genetic mechanism regulating our internal body clock.

13 Dec 2007

Novel technique using computer modeling identifies potential side effects of pharmaceuticals

Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.

12 Dec 2007

FDA and Pharsight continue to collaborate under CRADA

Pharsight Corporation has provided an update on its Cooperative Research and Development Agreement (CRADA) with the Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER).

12 Dec 2007

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

10 Dec 2007

Depression nearly triples the risk of death following a heart attack

...even when accounting for other heart attack risk factors, according to research presented at the American College of Neuropsychopharmacology (ACNP) annual meeting, which showed that among 360 depressed, post myocardial infarction patients followed for more than six years, those who did not recover from their depression in the first six months were more than twice as likely to die.

10 Dec 2007

Genetic markers for mental illness

Researchers have discovered natural genetic differences that might help predict the most effective antipsychotic drugs for particular patients with mental disorders such as schizophrenia, Parkinson's and drug addiction.

4 Dec 2007

Perchlorate contamination of drinking water may pose a greater health risk than previously thought

Scientists at the Albert Einstein College of Medicine of Yeshiva University have shown that perchlorate - an industrial pollutant linked to thyroid ailments - is actively concentrated in breast milk.

4 Dec 2007

Neuromuscular consequences of reflexive covert orienting

The person you're speaking with may be looking at you, but are they really paying attention? Or has the person covertly shifted their attention, without moving their eyes? Dr. Brian Corneil, of the Centre for Brain and Mind at The University of Western Ontario in London, Canada has found a way of actually measuring covert attention.

2 Dec 2007

Queen's University Belfast opens new centre for cancer research

Queen's Chancellor Senator George Mitchell officially opened the University's new £25M cancer research centre aimed at stopping the spread of cancer.

29 Nov 2007

BioMarin files investigational NDA for PEG-PAL for the treatment of phenylketonuria

BioMarin Pharmaceutical Inc. has announced that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for PEG-PAL (Poly Ethylene Glycol-Phenylalanine Ammonia Lyase), formerly known as Phenylase, for the treatment of phenylketonuria (PKU).

27 Nov 2007